Clinical trial
Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A…
NCT00446680 · Syntara, Industry · Completed
Key facts
| NCT number | NCT00446680 |
|---|---|
| Title | Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study |
| Official title | Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study |
| Lead sponsor | Syntara, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Mannitol, placebo |
| Enrollment | 340 |
| Start date | Mar 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Mar 13, 2007 |
| Last update posted | Jun 25, 2010 |
| Countries | Australia, Ireland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: